» Articles » PMID: 36852252

Protein-based Salivary Biomarkers for the Diagnosis of Periodontal Diseases: Systematic Review and Meta-analysis

Overview
Specialty General Medicine
Date 2023 Feb 28
PMID 36852252
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This systematic review and meta-analysis was aimed at determining differentially expressed protein-based biomarkers detectable in the saliva for the diagnosis of major periodontal diseases.

Methods: A literature review was conducted through January 31, 2022. The methodological quality and risk of bias were assessed with the Newcastle-Ottawa scale for case-control studies. Heterogeneity among studies was analysed with the Q statistical test and the I test. p-values lower than 0.10 and I values higher than 50% indicated high heterogeneity among studies; therefore, the random-effects model was used. The analysis of biological pathways associated with the differentially expressed protein markers was performed with the STITCH integration analysis tool and was limited to interactions with high confidence levels (0.7).

Results: Of all protein-based biomarkers detected, 12 were suitable for meta-analysis: IL-1β, MIP-1α, albumin, TNF-α, ICTP, Ig-A, lactoferrin, MMP-8, IL-6, IL-8, IL-17 and PGE2. The salivary markers with high applicability were IL-1β for differentiating patients with chronic periodontal disease from patients with gingivitis with an OE = 73.5 pg/mL; ICTP for differentiating patients with chronic periodontal disease from healthy control patients with an OE = 0.091 ng/mL; and PGE2 for differentiating patients with chronic periodontal disease from healthy control patients with an OE = 36.3 pg/mL.

Conclusions: The biomarkers with the highest differential expression and the greatest potential for clinical applicability are IL-1β for differentiating periodontitis from gingivitis, and ICTP and PGE2 for differentiating periodontitis from healthy status.

Citing Articles

Beneficial effects of non-invasive physical plasma on human periodontal ligament cells .

Eggers B, Seher L, Marciniak J, Pauck T, Deschner J, Eick S Front Med (Lausanne). 2024; 11:1443368.

PMID: 39629237 PMC: 11611554. DOI: 10.3389/fmed.2024.1443368.


Diagnostic Potential of Salivary Interleukin-1 and IL-10 for Distinguishing Periodontal Health From Periodontitis and Stable From Unstable Periodontitis: A Case-Control Study.

Raheem Z, Abdulbaqi H Int J Dent. 2024; 2024:8006278.

PMID: 39445112 PMC: 11496579. DOI: 10.1155/2024/8006278.


A Roadmap for the Rational Use of Biomarkers in Oral Disease Screening.

Cirillo N Biomolecules. 2024; 14(7).

PMID: 39062501 PMC: 11274832. DOI: 10.3390/biom14070787.

References
1.
Fine D, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C . Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease?. J Periodontol. 2009; 80(1):106-13. DOI: 10.1902/jop.2009.080296. View

2.
Finoti L, Nepomuceno R, Pigossi S, Corbi S, Secolin R, Scarel-Caminaga R . Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2017; 96(22):e6932. PMC: 5459707. DOI: 10.1097/MD.0000000000006932. View

3.
Napimoga M, Nunes L, Maciel A, Demasi A, Benatti B, Santos V . Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. Scand J Immunol. 2011; 74(6):596-602. DOI: 10.1111/j.1365-3083.2011.02605.x. View

4.
Lang N, Bartold P . Periodontal health. J Clin Periodontol. 2018; 45 Suppl 20:S9-S16. DOI: 10.1111/jcpe.12936. View

5.
Rangbulla V, Nirola A, Gupta M, Batra P, Gupta M . Salivary IgA, Interleukin-1β and MMP-8 as Salivary Biomarkers in Chronic Periodontitis Patients. Chin J Dent Res. 2017; 20(1):43-51. DOI: 10.3290/j.cjdr.a37741. View